Patient Benefits of CGM

ICR and CF Dosing Regimen

Discover how your MDI patients on this dosing regimen can benefit from CGM use.

You are here

How CGM Use Benefits Patients on ICR and CF Dosing Regimen

  • View continuous and timely feedback on diet, exercise, and insulin requirements to help make informed diabetes management decisions
  • Help reduce hypoglycemic and hyperglycemic events and increase time in glucose target range1
  • Help reduce A1C, time spent in hypoglycemia, and glycemic variability1

VIEW FIXED PRANDIAL DOSING REGIMEN

Meet Jake

32-year-old with type 1 diabetes for 12 years

  • A1C is 7.8%; Has ICR of 1 unit:15 grams CHO; CF of 1 unit:50 mg/dL
  • Exercises 3-4 times/week; Has some hypoglycemia (~2x/week)
  • Tries to take care of his diabetes; desires good control
  • Tests his blood sugar 4-6x/day
  • Refuses to be on pump; tried continuous glucose monitoring (CGM) when newly diagnosed but wasn't impressed with it

*Hypothetical patient profile; for training purposes only

Download Profile

Jake without CGM

Jake with CGM

1

Soupal J, Petruzelkova L, Flekac M, et al. Comparison of Different Treatment Modalities for Type 1 Diabetes, Including Sensor-Augmented Insulin Regimens, in 52 Weeks of Follow-Up: A COMISAIR Study. Diabetes Technol Ther. 2016;18(9):532-538.

Contact Dexcom

If you are a clinician and want to learn more about Dexcom’s Continuous Glucose Monitoring Systems, please fill out the form and a Dexcom representative will contact you.

If you are a Dexcom User or Patient, please contact Dexcom here.

The information you provide will be sent securely and subject to the Dexcom Terms of Use and Privacy Policy.